- Home
- SLQT vs ORIC Comparison
SLQT vs ORIC Comparison
Compare SLQT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLQT | ORIC |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.7M | 1.4B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLQT | ORIC |
|---|---|---|
| Price | $0.54 | $13.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $2.88 | ★ $19.73 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,618,499,000.00 | N/A |
| Revenue This Year | $10.97 | N/A |
| Revenue Next Year | $6.14 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 6.02 | N/A |
| 52 Week Low | $0.48 | $7.23 |
| 52 Week High | $2.35 | $14.93 |
Technical Indicators
Market Signals| Indicator | SLQT | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 31.48 | 57.47 |
| Support Level | N/A | $13.12 |
| Resistance Level | $0.79 | $14.27 |
| Average True Range (ATR) | 0.06 | 0.65 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 13.92 | 37.38 |
Price Performance
Historical ComparisonAbout SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.